Evidence map›Paper›PMID 40515956›Full record

SynthesisClinical and experimental medicine2025

AI-driven techniques for detection and mitigation of SARS-CoV-2 spread: a review, taxonomy, and trends.

Mohsen Ghorbian, Saied Ghorbian, Mostafa Ghobaei-Arani

Abstract readSystematic Review
In one paragraph

Synthesis in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohsen GhorbianDepartment of Computer Engineering, Qo.C., Islamic Azad University, Qom, Iran.
Saied GhorbianDepartment of Biology, Ta.C., Islamic Azad University, Tabriz, Iran.
Mostafa Ghobaei-AraniDepartment of Computer Engineering, Qo.C., Islamic Azad University, Qom, Iran. mo.ghobaei@iau.ac.ir.ORCID http://orcid.org/0000-0003-2639-0900

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 RNA virus, with its rapid spread and frequent genetic changes, has posed unparalleled obstacles for public health and treatment efforts. Early diagnosis of the disease and the development of effective treatment strategies are the main pillars of epidemic control. In this regard, machine learning (ML) methods, an advanced subset of artificial intelligence (AI), can play an effective role in improving the accuracy of diagnosis and the effectiveness of treatments related to SARS-CoV-2. However, the implementation of ML in clinical settings faces issues such as data heterogeneity, lack of training data, model interpretability challenges, patient privacy protection, and implementation limitations. This article provides a systematic review of the applications of federated learning (FL), deep learning (DL), reinforcement learning (RL), and hybrid approaches in the field of SARS-CoV-2 diagnosis and treatment. Based on the analysis of the results, the main focus of the research was on increasing privacy and security (P&S) with a share of 26%, improving detection accuracy and robustness (DAR) with 24%, and improving computational and communication efficiency (CCE) with 20%. These statistics indicate the importance of prioritizing patient information confidentiality and improving systems' accuracy and stability against data variability. In conclusion, the findings of this review can pave the way for the practical application of ML technologies in clinical decision-making and improving the quality of healthcare services related to SARS-CoV-2.

Indexed as

Artificial IntelligenceCOVID-19SARS-CoV-2HumansMachine LearningDeep learningDisease detectionFederated learningMachine learningSARS-CoV-2 detectionSARS-CoV-2 virus

Identifiers

PMID40515956
PMCPMC12167255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.